JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 15 No. 10 856-862
© 1974 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McIntyre, P. A.
Right arrow Articles by Hodkinson, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McIntyre, P. A.
Right arrow Articles by Hodkinson, B. A.

Comparison of the Metabolism of Iron-Labeled Transferrin (Fe·TF) and Indium-Labeled Transferrin (In·TF) by the Erythropoietic Marrow

Patricia A. McIntyre, Steven M. Larson, Edward A. Eikman, Martin Colman, Ursula Scheffel and Barbara A. Hodkinson

The Johns Hopkins Medical Institutions, Baltimore, Maryland

Correspondence: For reprints contact: Patricia A. McIntyre, 615 N. Wolfe St., Baltimore, Md. 21205.

ABSTRACT

Indium-111-transferrin (TF) has been described as a hematopoietic marrow scanning agent. The purpose of this study was to compare the metabolism of In·TF and Fe·TF by the erythropoietic marrow. There were marked differences observed between the biologic behavior of these two metals bound to transferrin in all parameters studied. These include: (A) slower plasma clearance of In·TF; (B) significantly greater percentage of 59Fe incorporation in the circulating red cells with only minimal labeling of peripheral red cells with indium and rapid disappearance of the indium-labeled cells from the circulation; (C) significantly greater accumulation of 59Fe in the skeleton; (D) irradiated rabbits' legs showed the expected bone and bone marrow decrease in the uptake of 59Fe-transferrin at 48 hr following 500 rads to the right tibia-fibula unit but no change in 111In·TF or 99mTc-sulfur colloid uptake; (E) in the control nonirradiated legs, 60% of the 59Fe but only 20% of 111In was in the extracted marrow, indicating that the bone concentration of indium was greater than that of 59Fe (p < 0.001); (F) a more rapid uptake of 59Fe·TF by reticulocyterich blood which at 60 min was nine times that of In·TF. These results suggest that the metabolism of indium is significantly different from that of iron with respect to erythropoiesis. The use of 111In·TF as a bone marrow scanning agent must be approached with caution in view of the high indium-to-iron ratio in normal bone and the unchanged accumulation of indium by bone marrow in which the erythroid marrow has been damaged by irradiation.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1974 by the Society of Nuclear Medicine.